[Experiments with a new drug in chronic liver diseases, especially alcohol-induced].
D000328:Adult; D000368:Aged; D001578:Benzopyrans / Q000627:therapeutic use*; D001663:Bilirubin / Q000097:blood; D002392:Catechin / Q000494:pharmacology / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004361:Drug Tolerance; D005260:Female; D006801:Humans; D007070:Immunoglobulin A / Q000032:analysis; D008104:Liver Cirrhosis, Alcoholic / Q000188:drug therapy; D008108:Liver Diseases, Alcoholic / Q000188:drug therapy*; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D011516:Prothrombin / Q000032:analysis; D013448:Sulfobromophthalein
D001578:Benzopyrans; D007070:Immunoglobulin A; D013448:Sulfobromophthalein; D002392:Catechin; D011516:Prothrombin; D001663:Bilirubin
Sperimentazione di un nuovo farmaco nelle epatopatie croniche soprattutto etiliche.